UCB Australia's epilepsy treatment Briviact (brivaracetam) is the subject of a new TGA Australian Public Assessment Report (AusPAR).
Briviact is presented as immediate release film coated tablets, oral solution and a solution for injection to be used as add-on therapy in the treatment of partial-onset seizures - see tga.gov.au for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Apr 17
